Must-Know Finance Concepts for Life Sciences Valuations This webinar presents an introduction to the key concepts and most common methodologies used to evaluate life sciences assets. Best Practices & Trends BioPharma Life Sciences Valuation Webinars
M&A in the $800B+ Global Packaging Industry In this webinar learn the numbers and trends, explore what's attracting investors, learn who the investors are, and discover how investors use M&A to further their strategies in the packaging industry. Best Practices & Trends Finance Mergers & Acquisitions Other Topics Webinars
Precision Medicine in Central Nervous System Drug Development Precision medicine, which has been pioneered by the field of oncology, aims to target the right treatments to the right patients at the right time. Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers
Microbiome: Hope or Hype? This whitepaper discusses how will microbiome impact human therapeutics, who's driving it, and why. Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers
The Nuts & Bolts of Selecting a Contract Research Organization This whitepaper discusses how to determine internal champions/selection committees, strategic sourcing/Procurement workflow/checklist, documentation and regulations, challenges of CRO outsourcing, and best practices to get best value. Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers
M&A Integration‚ Maximizing the Return on Technology and Talent This whitepaper delves into the web panel discussion – "M&A Integration: Maximizing Return on Technology & Talent" addressing key areas of focus that help drive business decisions related to technology and talent. Best Practices & Trends Finance Mergers & Acquisitions Other Topics Whitepapers
Gene & Cell Therapies This whitepaper explores the state-of-the-art, the potential and challenges ahead for advanced therapies. Best Practices & Trends BioPharma Life Sciences Other Topics Whitepapers
Maximizing M&A Value, Minimizing Surprises This white paper discusses key M&A trends and common reasons why realized value is often lower than expected value during the deal process. Best Practices & Trends Finance Mergers & Acquisitions Valuation Whitepapers
Best Practices for Responding to Inbound M&A Solicitations This white paper focuses on the various types of buyers and their motivations, how to determine if entertaining an offer is the right decision for your business, how to determine the seller’s goals and roles post sale, what not to do when responding to offers, and how to match your desired outcome with the appropriate type of buyer. Best Practices & Trends Finance Mergers & Acquisitions Whitepapers
Non-Immuno-Oncology and Immuno-Oncology Partnering and Development: What’s the Role of Non-IO in an IO World? This whitepaper discusses the role of non-immuno-oncology therapies for cancer in a world where immuno-oncology is playing a greater role. Best Practices & Trends BioPharma Life Sciences Other Topics Series Whitepapers
The Seven Deadly Sins of M&A In this whitepaper, David Stastny summarizes the "seven deadly sins" that cause reduced purchase prices or failed M&A exits. Best Practices & Trends Finance Mergers & Acquisitions Other Topics Whitepapers
Building a Better Partnering Presentation Whether seeking a partnership with another company to obtain funds, or looking to advance a drug candidate or technology, organizations need to present opportunities as attractively as possible to persuade potential partners. Best Practices & Trends BioPharma Licensing & Partnering Life Sciences Series Whitepapers